Annual Total Debt
$45.51 M
+$43.98 M+2882.31%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual total debt is $45.51 million, with the most recent change of +$43.98 million (+2882.31%) on December 31, 2023.
- During the last 3 years, VRCA annual total debt has risen by +$8.30 million (+22.32%).
- VRCA annual total debt is now at all-time high.
Performance
VRCA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$47.11 M
+$803.00 K+1.73%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly total debt is $47.11 million, with the most recent change of +$803.00 thousand (+1.73%) on September 30, 2024.
- Over the past year, VRCA quarterly total debt has increased by +$3.29 million (+7.52%).
- VRCA quarterly total debt is now at all-time high.
Performance
VRCA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
VRCA Total Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2882.3% | +7.5% |
3 y3 years | +22.3% | +2987.3% |
5 y5 years | +100.0% | +2987.3% |
VRCA Total Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +2882.3% | at high | +3316.5% |
5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Verrica Pharmaceuticals Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $47.11 M(+1.7%) |
Jun 2024 | - | $46.31 M(-0.3%) |
Mar 2024 | - | $46.44 M(+2.1%) |
Dec 2023 | $45.51 M(+2882.3%) | $45.51 M(+3.9%) |
Sep 2023 | - | $43.82 M(+3077.5%) |
Jun 2023 | - | $1.38 M(-5.0%) |
Mar 2023 | - | $1.45 M(-4.8%) |
Dec 2022 | $1.53 M(-96.5%) | $1.53 M(-4.3%) |
Sep 2022 | - | $1.59 M(-96.4%) |
Jun 2022 | - | $43.98 M(+0.7%) |
Mar 2022 | - | $43.65 M(+0.6%) |
Dec 2021 | $43.41 M(+16.7%) | $43.41 M(+0.7%) |
Sep 2021 | - | $43.12 M(+0.7%) |
Jun 2021 | - | $42.84 M(+0.7%) |
Mar 2021 | - | $42.53 M(+14.3%) |
Dec 2020 | $37.21 M | $37.21 M(+0.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2020 | - | $36.98 M(+6.1%) |
Jun 2020 | - | $34.84 M(+0.7%) |
Mar 2020 | - | $34.59 M(>+9900.0%) |
Dec 2019 | $188.00 K(>+9900.0%) | $188.00 K(-13.8%) |
Sep 2019 | - | $218.00 K(-12.1%) |
Jun 2019 | - | $248.00 K(-10.8%) |
Mar 2019 | - | $278.00 K(>+9900.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2018 | - | $0.00(0.0%) |
Jun 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00(0.0%) |
Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2017 | - | $0.00(0.0%) |
Jun 2017 | - | $0.00(0.0%) |
Mar 2017 | - | $0.00 |
Dec 2016 | $0.00 | - |
FAQ
- What is Verrica Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual total debt year-on-year change?
- What is Verrica Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly total debt year-on-year change?
What is Verrica Pharmaceuticals annual total debt?
The current annual total debt of VRCA is $45.51 M
What is the all time high annual total debt for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual total debt is $45.51 M
What is Verrica Pharmaceuticals annual total debt year-on-year change?
Over the past year, VRCA annual total debt has changed by +$43.98 M (+2882.31%)
What is Verrica Pharmaceuticals quarterly total debt?
The current quarterly total debt of VRCA is $47.11 M
What is the all time high quarterly total debt for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly total debt is $47.11 M
What is Verrica Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, VRCA quarterly total debt has changed by +$3.29 M (+7.52%)